MR microcirculation assessment in cervical cancer: Correlations with histomorphological tumor markers and clinical outcome

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 267-276

  Mayr, Nina A ^a,c   Hawighorst, Hans ^b   Yuh, William T C ^a   Essig, Marco ^b   Magnotta, Vincent A ^a   Knopp, Michael V ^b  

^a UNIVERSITY OF IOWA   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Division of Gynecologic Oncology   (United States)

Author keywords

Angiogensis; Dynamic contrast MRI; Hypoxia; Tumor microcirculation; Tumor responsiveness

Indexed keywords

GADOLINIUM PENTETATE; GADOTERIDOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; TUMOR MARKER;

ARTICLE; BOLUS INJECTION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; FEMALE; FIRST PASS EFFECT; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MICROCIRCULATION; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0032875831     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<267::AID-JMRI7>3.0.CO;2-Y     Document Type: Article

References (74)

1. Lanciano R, Won M, Hanks G. A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical cancer. A study of patterns of care. Cancer 1992;69:482-487.
2. Perez C, Fox S, Lockett M, et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 1991;21:885-898.
3. Komaki R, Brickner T, Hanlon A, Owen J, Hanks G. Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: patterns of care study (PCS). Int J Radiation Oncology Biol Phys 1995:31:978-982.
4. Perez C, Grigsby P, Nene S, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992;69:2796-2806.
5. Barillot I, Horiot J, Pigneux J, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostic factors. Int J Radiat Oncology Biol Phys 1997;38:969-978.
6. Morris M, Eifel P, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137.
7. Gray L, Conger A, Ebert M. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-648.
8. Thomlinson R, Gray L. The histologic structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-549.
9. Bush R, Jenkin R, Allt W. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 1978;37(suppl 3):302-306.
10. Evans J, Bergso P. The influence of anemia and results of radiotherapy in carcinoma of the cervix. Radiology 1965;48:709-717.
11. Gatenby R, Kessler H, Rosenblum J, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome to radiation therapy. Int J Radiat Oncol Biol Phys 1988;14: 831-838.
12. 2-histography. Int J Radiat Oncol Biol Phys 1990;19:953-961.
13. Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest 1968;106(suppl):145-157.
14. Latargau E, Randranarivelo H, et al. Oxygen tension measurements in human tumors: the Institute Gustave-Roussy experience. Radiat Oncol Invest 1994;1:285-291.
15. Tannock I. The relation between cell proliferalion and the vascular system in a transplanted mouse mammary tumor. Br J Cancer 1968;22:258-273.
16. Dische S, Anderson P, Sealy R, Watson E. Carcinoma of the cervix - anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 1983;56:251-255.
17. Urtasun R, Chapman J, Raleigh J, et al. Binding of H-3-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys 1986;12:1263-1267.
18. Beaney R, Lammertsma A, Jones T, McKenzie C, Halnan K. Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet 1984;1:131-134.
19. Ito M, Lammertsma A, Wise R, et al. Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumors using O-15 and positron emission tomography: analytical techniques and preliminary results. Neuroradiology 1982;23:63-74.
20. Mayr N, Yuh W, Magnotta V, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer - a new non-invasive predictive assay. Int J Radiat Oncol Biol Phys 1996;36:623-633.
21. Mayr N, Yuh W, Zheng J, et al. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. Am J Roentgenol 1998;170:177-182.
22. Hawighorst H, Weikel W, Knapstein P, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998;4:2305-2312.
23. Hawighorst H, Knapstein P, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57:4777-4786.
24. Deschner E, Gray L. Influence of oxygen tension on x-ray-induced chromosomal damage in Ehrlich ascites tumor cells irradiated in vitro and in vivo. Radiat Res 1959;11:1115-1146.
25. Kallinowski F, Schienger K, Kloes M, et al. Tumor blood flow: the principle modulator of oxidative glycolytic metabolism, and of the metabolic micromileu of human tumor xenografts in vivo. Int J Cancer 1989;44:266-272.
26. Kallinowski F, Schlenger K, Runkel S, et al. Blood flow, metabolism, cellular micro-environment, and growth rate of human tumor xenografts. Cancer Res 1989;49:3759-3764.
27. Vaupel P, Fortmeyer H, Runkel S, et al. Blood flow, oxygen consumption and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 1987;47:3496-3503.
28. Peters L, Brock W, Chapman J, et al. Predictive assays of tumor radiocurability. Am J Clin Oncol 1988;11:275-287.
29. Jain R, Ward-Hartley K. Tumor blood flow: characterization, modifications, and role of hyperthermia. IEEE Trans Sonics Ultrasonics 1984;SU:31.
30. Tannock I. Response of aerobic and hypoxic cell in a solid tumor to Adriamycin and cyclophosphamide, and interaction of the drugs with radiation. Cancer Res 1982;42:4921-4926.
31. Mendenhall W, Thar T, Bova F, et al. Prognostic and treatment factors affecting pelvic control of stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984;53:2649-2654.
32. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26: 45-50.
33. Eifel P, Morris M, Wharton J, et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9-16.
34. Eifel P, Thomas W, Smith T, et al. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. J Radiation Oncol Biol Phys 1993;28:113-118.
35. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
36. Tannock I. Oxygen diffusion and the distribution of cellular radiosensitivity in tumors. Br J Radiol 1972;45:515-524.
37. Brown J. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979;52:650-656.
38. Chaplin D, Olive P, Durand R. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 1987;47:597-601.
39. Neeman M, Abramovitch R, Schiffenbauer Y, Tempel C. Regulation of angiogenesis by gypoxic stress: from solid tumors to the ovarian follicle. Int J Exp Pathol 1997;78:57-70.
40. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multiple spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-772.
41. Guichard M, Dertinger H, Malaise E. Radiosensitivity of four human tumor xenografts. Influence of hypoxia and cell-cell contact. Radiat Res 1983;95:602-609.
42. NageleT, Petersen D, Klose U, et al. Dynamic contrast enhancement of intracranial tumors with snapshot-FLASH MR imaging. AJNR 1993;14:89-98.
43. Fujii K, Fujita N, Hirabuki N, et al. Neuromas and meningiomas: evaluation of early enhancement with dynamic MR imaging. AJNR 1992;13:1215-1220.
44. Yuh W, Tali E, Nguyen H, et al. The effect of contrast dose, imaging time, and lesion size in the detection of intracerebral metastasis. AJNR 1995;16:373-380.
45. Yuh W, Mayr N, Zheng J, et al. Can combined volume and perfusion analysis improve the prediction of tumor control in cervical cancer? (abstr). Int J Radiat Oncol Biol Phys 1996;36:323.
46. Mayr N, Magnotta V, Pelsang R, et al. Usefulness of tumor volumetry by magnetic resonance (MR) imaging in assessing response to radiation therapy in carcinoma of the uterine cervix (abstr). Radiology 1995;197(P):153.
47. Knopp M, Brix G, Junkermann H, et al. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin North Am 1994;2:633-658.
48. Hawighorst H, Knapstein P, Weikel W, et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996;201:531-539.
49. Hawighorst H, Block M, Knopp M, et al. Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences. Magn Reson Imaging 1998;16:225-234.
50. Hawighorst H, Engenhart R, Knopp M. Intracranial meningiomas: time and dose dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. Magn Reson Imaging 1997;15:423-432.
51. Hawighorst H, Knopp M, Debus J, et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging. 1998;8:783-788.
52. Weng F, Rempp K, Hess T. Effect of radiation on blood flow volume in low-grade astrocytomas and normal brain tissue. AJR Am J Radiol 1996;166:187-193.
53. Delorme S, Knopp M. Non-invasive vascular imaging: assessing tumour vascularity [review]. Eur Radi 1998;8:517-527.
54. Maeda M, Itoh S, Kimura H, et al. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR 1994;163:181-186.
55. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-283.
56. Verstraete K, De-Deene Y, Roels H, et al. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging: parametric first-pass images depict tissue vascularization and perfusion. Radiology 1994;192:835-843.
57. Buade L, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200:639-649.
58. Degani H, Gussi V, Weinstein D, et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nature Med 1997;3:780-782.
59. Hoffmann U, Brix G, Knopp M, Hess T, Lorenz W. Pharmacokinetic mapping of the breast: a new method for dynamic MR-mammography. Magn Reson Med 1995;33:506-514.
60. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-727.
61. Koenig H, Sieper J, Wolf K. Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with enhanced dynamic MR imaging enhanced with Gd-DTPA. Radiology 1990;176:473-477.
62. Takashima S, Noguchi Y, Okumara T, Aruga H, Kobayashi T. Dynamic MR imaging in the head and neck. Radiology 1993;189: 813-821.
63. Brix G, Rempp K, Guckel F, et al. Quantitative assessment of tissue microcirculation by dynamic contrast-enhanced MR imaging. Adv Magn Reson Imaging Contrast 1994;2:68-77.
64. Yuh W, Mayr N, Arnholt J, et al. Pixel analysis of MR perfusion imaging in predicting treatment outcome in cervical cancer (abstract). Int J Radiat Oncol Biol Phys 1997;39:298.
65. Mayr N, Tali E, Yuh W, et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology 1993;189:601-608.
66. Mayr N, Magnotta V, Ehrhardt J, et al. Usefulness of tumor volumetry in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1996;35:915-925.
67. Brizel D, Rosner G, Prosnitz L, et al. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas and lymph node metastases. Int J Radiat Oncol Biol Phys 1995;32:1121-1125.
68. Mlynek M-L, van Beunigen D, Leder L-D, Streffer C. Measurement of the grade of vascularisation in histological tumour tissue sections. Br J Cancer 1985;52:945-948.
69. 18[F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36:417-428.
70. Wong R, Flyles A, Milosevic M, et al. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. Int J Radiat Oncol Biol Phys 1997;39:405-412.
71. Hess T, Mueller-Schimpfle M, Brix G, et al. Dynamic Gd-DTPA enhanced MRI in the follow-up of cervical carcinoma after combined radio/chemotherapy. Adv Magn Reson Imaging Contrast 1994;2: 85-93.
72. Hulka C, Edmister W, Smith B, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842.
73. Postema S, Pattynama P, van Rijswijk C, et al. Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumor aggressiveness? Radiology 1999;210:217-220.
74. Stein I, Neeman M, Shweiki D, et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995;15:5363-5368.